✦ LIBER ✦

Randomized phase II study of three doses of the integrin inhibitor cilengitide versus docetaxel as second-line treatment for patients with advanced non-small-cell lung cancer

✍ Scribed by Christian Manegold, Johan Vansteenkiste, Felipe Cardenal, Wolfgang Schuette, Penella J. Woll, Ernst Ulsperger, Anne Kerber, Josef Eckmayr, Joachim von Pawel

Book ID: 118299122
Publisher: Springer US
Year: 2012
Tongue: English
Weight: 250 KB
Volume: 31
Category: Article
ISSN: 0167-6997
DOI: 10.1007/s10637-012-9842-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized phase III study of the doce

A randomized phase III study of the docetaxel/carboplatin combination versus docetaxel single-agent as second line treatment for patients with advanced/metastatic Non-Small Cell Lung Cancer

✍ Athanasios G Pallis; Sophia Agelaki; Athina Agelidou; Ioannis Varthalitis; Kosta 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 359 KB

Randomized Multicenter Phase II Study of

Randomized Multicenter Phase II Study of Gemcitabine Versus Docetaxel as First-Line Therapy with Second-Line Crossover in Advanced-Stage Non–Small-Cell Lung Cancer

✍ Christian Manegold; Lothar Richard Pilz; Gabriele Koschel; Katrin Schott-von Röm 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 158 KB

Phase II study of low-dose weekly paclit

Phase II study of low-dose weekly paclitaxel as second-line treatment for advanced non-small cell lung cancer

✍ O. Juan; V. Alberola; A. Rocher; R. Casany; V. Carañana; J.M. Campos; A. Albert; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 347 KB

9001 Vandetanib plus docetaxel versus do

9001 Vandetanib plus docetaxel versus docetaxel as second-line treatment for patients with advanced non-small-cell lung cancer (NSCLC): a randomized, double-blind phase III trial

✍ Eberhardt, W.E.E.; Johnson, B.E.; Sun, Y.; Germonpré, P.; Saijo, N.; Zhou, C.; W 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Docetaxel versus docetaxel plus gemcitab

Docetaxel versus docetaxel plus gemcitabine as front-line treatment of patients with advanced non-small cell lung cancer: A randomized, multicenter phase III trial

✍ Georgoulias, Vassilis; Androulakis, Nikolaos; Kotsakis, Athanasios; Hatzidaki, D 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 239 KB

Open, Randomized, Phase II Study of Sing

Open, Randomized, Phase II Study of Single-Agent Gemcitabine and Docetaxel as First- and Second-Line Treatment in Patients with Advanced Non–Small-Cell Lung Cancer

✍ Christian Manegold; Gabriele Koschel; Dagmar Hruska; Kathrin Schott-von-Römer; J 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 155 KB